---
title: "Applied Therapeutics Executives Sell Shares for Tax Obligations"
date: "2025-02-08 09:40:00"
summary: "Reporter NameRelationshipTypeAmountSEC FilingChinoporos ConstantineOfficerSell$17,151Form 4Perfetti RiccardoChief Medical OfficerSell$52,507Form 4Funtleyder Leslie D.DirectorSell$13,999Form 4Several executives at Applied Therapeutics have recently sold shares of the company's common stock to cover tax obligations related to the vesting of Restricted Stock Units. Constantine Chinoporos, the Chief Operating Officer and Chief Business Officer, sold 28,117 shares..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

| Reporter Name | Relationship | Type | Amount | SEC Filing |
| --- | --- | --- | --- | --- |
| Chinoporos Constantine | Officer | Sell | $17,151 | [Form 4](https://www.sec.gov/Archives/edgar/data/2014509/000095017025016585/xslF345X05/ownership.xml) |
| Perfetti Riccardo | Chief Medical Officer | Sell | $52,507 | [Form 4](https://www.sec.gov/Archives/edgar/data/1775410/000095017025016587/xslF345X05/ownership.xml) |
| Funtleyder Leslie D. | Director | Sell | $13,999 | [Form 4](https://www.sec.gov/Archives/edgar/data/1775394/000095017025016588/xslF345X05/ownership.xml) |

Several executives at Applied Therapeutics have recently sold shares of the company's common stock to cover tax obligations related to the vesting of Restricted Stock Units.

Constantine Chinoporos, the Chief Operating Officer and Chief Business Officer, sold 28,117 shares at a price of $0.61 per share, totaling $17,151. Following this transaction, Chinoporos directly owns 271,883 shares of the company.

Riccardo Perfetti, the Chief Medical Officer, sold 86,078 shares at the same price, amounting to $52,507, and now directly owns 900,775 shares.

Leslie D. Funtleyder, a Director and the Interim Chief Executive Officer and Chief Financial Officer, sold 22,950 shares, also at $0.61 per share, for a total of $13,999. Post-transaction, Funtleyder directly owns 404,961 shares of Applied Therapeutics.

[TradingView](https://www.tradingview.com/news/tradingview:7845acfd38510:0-applied-therapeutics-executives-sell-shares-for-tax-obligations/)
